Medication info

Byetta Tablet 10/10 mg

Prescription medicationApproval withdrawn
Ingredient · strength
Ezetimibe›Strength being verifiedSimvastatin›Strength being verified
Manufacturer / importer
Poongrim Pharmaceutical Co., Ltd.
Appearance
White to light yellow, biconvex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Approval withdrawn

MFDS item code 201901141 · Approved 2019.02.22

This product's status changed to Approval withdrawn on 2023.08.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who uses it
Adults
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Poongrim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular diseases due to hypercholesterolemia
View approved original text

This medication helps to lower total cholesterol, LDL-cholesterol, ApoB, and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, while helping to raise HDL-cholesterol levels. It is also used as an adjunct to other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia or when other treatments are ineffective. This medication should be taken along with dietary therapy and should be effective when combined with non-pharmacological measures such as limiting saturated fat and cholesterol intake. It is important to identify and treat other conditions or medications that may cause dyslipidemia before administration. In patients with acute coronary events, lipid levels should also be evaluated to inform appropriate treatment initiation. Thus, this medication is used to regulate blood lipid levels associated with hypercholesterolemia and improve vascular health.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication helps lower blood cholesterol levels, reducing the risk of cardiovascular disease. However, when taking this medication, one should be cautious as symptoms such as muscle pain or weakness may occur. Particularly, serious muscle damage symptoms such as myopathy or rhabdomyolysis may rarely occur, and in such cases, one should consult a doctor immediately. This medication can affect liver function; therefore, it is advisable to avoid taking it if there is liver disease or if liver function test levels are abnormally high. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use it only if the chance of pregnancy is very low. Additionally, this medication can increase the risk of muscle damage when taken with certain antifungal agents, antibiotics, or immunosuppressants, so if other medications are being taken, it is essential to inform a doctor or pharmacist. It is important to regularly check liver function and muscle status through blood tests while taking this medication. Elderly patients or those with poor kidney function need to be more careful, and symptoms should be reported to healthcare personnel immediately. It is advisable to avoid grapefruit juice during treatment, and there is no specific antidote in the case of overdose, so one should visit a medical institution immediately.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 98 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • eczema
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • ophthalmoplegia
  • facial weakness
  • tremor
  • dizziness
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve paralysis
  • psychiatric disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive dysfunction
  • interstitial lung disease
  • anaphylaxis
  • lupus-like syndrome
  • polymyalgia rheumatica
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • elevated bilirubin
  • thyroid dysfunction
  • elevated serum creatine kinase
  • hepatitis
  • cholestasis jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • anorexia
  • vomiting
  • chest pain
  • chest discomfort
  • sensory loss
  • nocturia
  • hematuria
  • weight loss
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Also, it is best to store it at room temperature between 1 degree and 30 degrees. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White to light yellow, biconvex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.